- Home
- KYMR vs MSM Comparison
KYMR vs MSM Comparison
Compare KYMR & MSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- MSM
- Stock Information
- Founded
- KYMR 2015
- MSM 1941
- Country
- KYMR United States
- MSM United States
- Employees
- KYMR N/A
- MSM N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- MSM Industrial Machinery/Components
- Sector
- KYMR Health Care
- MSM Industrials
- Exchange
- KYMR Nasdaq
- MSM Nasdaq
- Market Cap
- KYMR 4.3B
- MSM 5.1B
- IPO Year
- KYMR 2020
- MSM 1995
- Fundamental
- Price
- KYMR $59.70
- MSM $85.86
- Analyst Decision
- KYMR Strong Buy
- MSM Hold
- Analyst Count
- KYMR 17
- MSM 5
- Target Price
- KYMR $63.76
- MSM $90.50
- AVG Volume (30 Days)
- KYMR 771.9K
- MSM 525.8K
- Earning Date
- KYMR 10-30-2025
- MSM 10-23-2025
- Dividend Yield
- KYMR N/A
- MSM 3.96%
- EPS Growth
- KYMR N/A
- MSM N/A
- EPS
- KYMR N/A
- MSM 3.54
- Revenue
- KYMR $44,711,000.00
- MSM $3,743,630,000.00
- Revenue This Year
- KYMR $62.11
- MSM N/A
- Revenue Next Year
- KYMR N/A
- MSM $4.38
- P/E Ratio
- KYMR N/A
- MSM $24.27
- Revenue Growth
- KYMR N/A
- MSM N/A
- 52 Week Low
- KYMR $19.45
- MSM $68.10
- 52 Week High
- KYMR $63.96
- MSM $94.31
- Technical
- Relative Strength Index (RSI)
- KYMR 62.28
- MSM 38.08
- Support Level
- KYMR $58.00
- MSM $84.20
- Resistance Level
- KYMR $63.96
- MSM $87.56
- Average True Range (ATR)
- KYMR 2.65
- MSM 2.07
- MACD
- KYMR 0.00
- MSM -0.64
- Stochastic Oscillator
- KYMR 56.84
- MSM 19.01
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.